Share Price and Basic Stock Data
Last Updated: October 18, 2025, 8:27 pm
| PEG Ratio | 27.90 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fundviser Capital (India) Ltd operates in the Finance & Investments sector, with its recent share price reported at ₹191 and a market capitalization of ₹113 Cr. The company’s revenue trends exhibit significant volatility, with sales recorded at ₹0.02 Cr in Jun 2022, gradually rising to ₹0.62 Cr in Sep 2023, before reaching ₹0.97 Cr in Mar 2024. However, a decline to ₹0.25 Cr was noted in Mar 2025, indicating inconsistent revenue generation. Expenses have also fluctuated, standing at ₹0.05 Cr in Jun 2022 and increasing to ₹0.77 Cr in Mar 2025. The operating profit margin (OPM) has seen a remarkable turnaround, moving from a negative -150.00% in Jun 2022 to a positive 61.86% in Mar 2024, before declining again to 26.27% in Mar 2025. This erratic performance highlights the challenges the company faces in establishing a stable revenue stream in a competitive market.
Profitability and Efficiency Metrics
Fundviser Capital’s profitability indicators reflect both improvement and ongoing challenges. The net profit reported for Mar 2025 was ₹0.43 Cr, with an earnings per share (EPS) of ₹0.83, which is a recovery from a negative EPS in previous quarters. The return on equity (ROE) stood at 2.88%, while the return on capital employed (ROCE) was reported at 3.76%, both of which are relatively low compared to industry standards, suggesting that the company may not be fully utilizing its equity and capital. The interest coverage ratio is notably strong at 24.74x, indicating ample capacity to cover interest obligations. However, the cash conversion cycle has increased to 79.06 days, which may indicate inefficiencies in managing receivables and payables. While the company has shown the ability to generate profits in certain quarters, the overall inconsistency raises concerns about sustained profitability.
Balance Sheet Strength and Financial Ratios
Fundviser Capital maintains a balanced financial position with no reported borrowings, reflecting a debt-free status. As of Mar 2025, total reserves stood at ₹11.43 Cr, providing a cushion for future operations. The company’s total assets reached ₹16.81 Cr, with a debt-to-equity ratio of 0.39, suggesting a conservative leverage approach. The current and quick ratios, both at 1.33, indicate adequate liquidity to meet short-term obligations. However, the price-to-book value ratio is relatively high at 4.04x, which may suggest overvaluation in the eyes of investors. The interest coverage ratio of 24.74x further emphasizes the company’s ability to meet its interest expenses without incurring debt. Overall, the financial ratios indicate a stable balance sheet, but the high valuation metrics could deter potential investors if not justified by future growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fundviser Capital indicates a strong promoter presence, with promoters holding 66.36% as of Jun 2025. This significant stake reflects confidence from the founding members in the company’s long-term prospects. Foreign Institutional Investors (FIIs) are absent, while Domestic Institutional Investors (DIIs) hold a modest 0.42%. The public shareholding stands at 33.22%, with a gradual decline in shareholder numbers from 4,070 in Sep 2022 to 3,710 in Jun 2025. This trend may raise concerns about investor sentiment and market interest. The fluctuations in public shareholding, particularly with a notable drop to 0.00% in Dec 2023, suggest potential volatility in investor confidence. With the majority of the shares held by promoters, the company is somewhat insulated from market fluctuations, but the lack of institutional backing could limit broader market appeal.
Outlook, Risks, and Final Insight
If margins sustain their improvement trajectory, Fundviser Capital could leverage its strong financial ratios to attract more investors and potentially expand its market share. However, the company faces significant risks, including its erratic revenue trends, which could hinder growth and profitability if not managed effectively. The absence of debt provides flexibility, but it may also limit growth opportunities that could arise from strategic leveraging. Additionally, the declining public shareholder base raises concerns about market sentiment and investor engagement. If the company can stabilize its revenue generation and improve its operational efficiency, it may enhance its profitability and investor confidence. Ultimately, Fundviser Capital’s ability to navigate these challenges will determine its long-term viability in the competitive finance and investment sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fundviser Capital (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.1 Cr. | 41.3 | 67.7/36.4 | 43.2 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,445 Cr. | 308 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.49 Cr. | 9.08 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.4 Cr. | 47.6 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,763.07 Cr | 1,429.69 | 132.51 | 3,769.18 | 0.31% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.02 | 0.03 | -0.03 | 0.02 | 0.62 | 0.08 | 0.25 | 0.01 | 0.00 | 0.32 | 0.61 | 0.32 |
| Expenses | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.20 | 0.04 | 0.09 | 0.70 | 0.77 | 0.64 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.09 | -0.38 | -0.16 | -0.32 |
| OPM % | -150.00% | -150.00% | -100.00% | -200.00% | 91.94% | 12.50% | 20.00% | -300.00% | -118.75% | -26.23% | -100.00% | ||
| Other Income | 0.01 | 0.02 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.10 | 0.12 | 0.20 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Profit before tax | -0.02 | -0.01 | 0.12 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.08 | 0.72 | -0.04 | -0.13 |
| Tax % | 0.00% | 0.00% | 16.67% | -10.00% | -25.00% | 12.28% | 400.00% | 80.00% | -33.33% | -25.00% | 25.00% | -50.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | 0.10 | -0.09 | -0.03 | 0.50 | -0.03 | 0.00 | -0.02 | -0.06 | 0.54 | -0.02 | -0.12 |
| EPS in Rs | -0.03 | -0.03 | 0.27 | -0.24 | -0.08 | 1.36 | -0.08 | 0.00 | -0.04 | -0.13 | 1.05 | -0.04 | -0.20 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Fundviser Capital (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.61 Cr. (Mar 2025) to 0.32 Cr., marking a decrease of 0.29 Cr..
- For Expenses, as of Jun 2025, the value is 0.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.77 Cr. (Mar 2025) to 0.64 Cr., marking a decrease of 0.13 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from -0.16 Cr. (Mar 2025) to -0.32 Cr., marking a decrease of 0.16 Cr..
- For OPM %, as of Jun 2025, the value is -100.00%. The value appears to be declining and may need further review. It has decreased from -26.23% (Mar 2025) to -100.00%, marking a decrease of 73.77%.
- For Other Income, as of Jun 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.13 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Mar 2025) to -0.13 Cr., marking a decrease of 0.09 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -50.00% (Mar 2025) to 0.00%, marking an increase of 50.00%.
- For Net Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears to be declining and may need further review. It has decreased from -0.02 Cr. (Mar 2025) to -0.12 Cr., marking a decrease of 0.10 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.20. The value appears to be declining and may need further review. It has decreased from -0.04 (Mar 2025) to -0.20, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:19 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.21 | 3.61 | 0.00 | 0.00 | 0.34 | 0.25 | 0.28 | 0.24 | 0.15 | 0.22 | 0.97 | 2.17 | 1.25 |
| Expenses | 3.82 | 3.78 | 1.85 | 0.39 | 0.34 | 0.29 | 0.23 | 0.20 | 0.21 | 0.23 | 0.37 | 1.60 | 2.20 |
| Operating Profit | -0.61 | -0.17 | -1.85 | -0.39 | 0.00 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 | -0.95 |
| OPM % | -19.00% | -4.71% | 0.00% | -16.00% | 17.86% | 16.67% | -40.00% | -4.55% | 61.86% | 26.27% | -76.00% | ||
| Other Income | 0.17 | 0.23 | 3.27 | 0.49 | 0.00 | 0.13 | 0.01 | 0.60 | 0.05 | 0.00 | 0.00 | 0.00 | 1.43 |
| Interest | 0.02 | 0.03 | 0.00 | 0.06 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.30 | 0.68 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Profit before tax | -0.76 | -0.65 | 1.41 | 0.04 | -0.02 | 0.07 | 0.06 | 0.64 | -0.01 | -0.01 | 0.59 | 0.56 | 0.47 |
| Tax % | -5.26% | -24.62% | -8.51% | 25.00% | 50.00% | 0.00% | 66.67% | 17.19% | 200.00% | 0.00% | 25.42% | 23.21% | |
| Net Profit | -0.73 | -0.48 | 1.53 | 0.02 | -0.03 | 0.07 | 0.02 | 0.52 | -0.03 | -0.01 | 0.44 | 0.43 | 0.34 |
| EPS in Rs | -1.98 | -1.30 | 4.15 | 0.05 | -0.08 | 0.19 | 0.05 | 1.41 | -0.08 | -0.03 | 1.19 | 0.83 | 0.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.25% | 418.75% | -98.69% | -250.00% | 333.33% | -71.43% | 2500.00% | -105.77% | 66.67% | 4500.00% | -2.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | 384.50% | -517.44% | -151.31% | 583.33% | -404.76% | 2571.43% | -2605.77% | 172.44% | 4433.33% | -4502.27% |
Fundviser Capital (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 47% |
| 3 Years: | 135% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 85% |
| 3 Years: | 154% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 100% |
| 3 Years: | 142% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:16 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 4.47 | 5.15 |
| Reserves | 0.73 | 0.25 | 1.78 | 2.04 | 2.00 | 2.08 | 2.10 | 2.62 | 2.52 | 2.79 | 8.76 | 11.43 |
| Borrowings | 0.42 | 0.13 | 0.40 | 0.19 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.55 | 0.20 | 0.14 | 0.05 | 0.06 | 0.03 | 0.20 | 0.13 | 0.02 | 0.06 | 0.09 | 0.23 |
| Total Liabilities | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 |
| Fixed Assets | 2.22 | 1.54 | 0.09 | 0.08 | 0.08 | 1.17 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.03 | 0.02 | 0.52 | 0.69 | 0.65 | 0.17 | 0.17 | 0.17 | 3.09 | 3.20 | 2.61 | 11.53 |
| Other Assets | 3.14 | 2.71 | 5.40 | 5.20 | 5.38 | 4.46 | 4.53 | 6.27 | 3.14 | 3.34 | 10.71 | 5.23 |
| Total Assets | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 |
Below is a detailed analysis of the balance sheet data for Fundviser Capital (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.15 Cr.. The value appears strong and on an upward trend. It has increased from 4.47 Cr. (Mar 2024) to 5.15 Cr., marking an increase of 0.68 Cr..
- For Reserves, as of Mar 2025, the value is 11.43 Cr.. The value appears strong and on an upward trend. It has increased from 8.76 Cr. (Mar 2024) to 11.43 Cr., marking an increase of 2.67 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Mar 2024) to 0.23 Cr., marking an increase of 0.14 Cr..
- For Total Liabilities, as of Mar 2025, the value is 16.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.32 Cr. (Mar 2024) to 16.81 Cr., marking an increase of 3.49 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.05 Cr., marking an increase of 0.05 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 11.53 Cr.. The value appears strong and on an upward trend. It has increased from 2.61 Cr. (Mar 2024) to 11.53 Cr., marking an increase of 8.92 Cr..
- For Other Assets, as of Mar 2025, the value is 5.23 Cr.. The value appears to be declining and may need further review. It has decreased from 10.71 Cr. (Mar 2024) to 5.23 Cr., marking a decrease of 5.48 Cr..
- For Total Assets, as of Mar 2025, the value is 16.81 Cr.. The value appears strong and on an upward trend. It has increased from 13.32 Cr. (Mar 2024) to 16.81 Cr., marking an increase of 3.49 Cr..
Notably, the Reserves (11.43 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.03 | -0.30 | -2.25 | -0.58 | -0.36 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.39 | 30.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Inventory Days | 65.51 | 11.36 | ||||||||||
| Days Payable | 10.92 | 0.00 | ||||||||||
| Cash Conversion Cycle | 90.98 | 41.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Working Capital Days | 185.34 | 121.33 | -21.47 | 160.60 | 26.07 | 2,843.96 | 97.33 | 49.77 | 989.64 | 518.06 | ||
| ROCE % | -13.70% | -14.81% | -2.01% | 1.70% | 0.67% | -0.17% | 1.04% | 0.99% | -0.16% | -1.42% | 6.09% | 3.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.17 |
| Diluted EPS (Rs.) | 4.50 |
| Cash EPS (Rs.) | 5.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.33 |
| Revenue From Operations / Share (Rs.) | 64.60 |
| PBDIT / Share (Rs.) | 5.79 |
| PBIT / Share (Rs.) | 5.75 |
| PBT / Share (Rs.) | 5.51 |
| Net Profit / Share (Rs.) | 5.17 |
| NP After MI And SOA / Share (Rs.) | 3.07 |
| PBDIT Margin (%) | 8.97 |
| PBIT Margin (%) | 8.89 |
| PBT Margin (%) | 8.53 |
| Net Profit Margin (%) | 8.00 |
| NP After MI And SOA Margin (%) | 4.75 |
| Return on Networth / Equity (%) | 8.45 |
| Return on Capital Employeed (%) | 11.64 |
| Return On Assets (%) | 2.90 |
| Total Debt / Equity (X) | 0.39 |
| Current Ratio (X) | 1.33 |
| Quick Ratio (X) | 1.33 |
| Interest Coverage Ratio (X) | 24.74 |
| Interest Coverage Ratio (Post Tax) (X) | 23.08 |
| Enterprise Value (Cr.) | 87.19 |
| EV / Net Operating Revenue (X) | 2.62 |
| EV / EBITDA (X) | 29.20 |
| MarketCap / Net Operating Revenue (X) | 2.27 |
| Price / BV (X) | 4.04 |
| Price / Net Operating Revenue (X) | 2.27 |
| EarningsYield | 0.02 |
After reviewing the key financial ratios for Fundviser Capital (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.22. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 64.60. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.79. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.75. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.51. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.07. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 8.00. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.75. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.45. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.64. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.74. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.08. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 87.19. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 29.20. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fundviser Capital (India) Ltd:
- Net Profit Margin: 8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.64% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.45% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 334 (Industry average Stock P/E: 132.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 22, 7th Floor, Manek Mahal, Next to Ambassador Hotel, Mumbai Maharashtra 400020 | info@fundvisercapital.in http://www.fundvisercapital.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishan Jain | Chairman & Wholetime Director |
| Mrs. Kriti Jain | Whole Time Director |
| Mr. Triloki Nath Bansal | Independent Director |
| Mr. Vinodkumar Singh | Independent Director |
| Mr. Suresh Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Fundviser Capital (India) Ltd?
Fundviser Capital (India) Ltd's intrinsic value (as of 18 October 2025) is 252.75 which is 31.64% higher the current market price of 192.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 113 Cr. market cap, FY2025-2026 high/low of 281/112, reserves of ₹11.43 Cr, and liabilities of 16.81 Cr.
What is the Market Cap of Fundviser Capital (India) Ltd?
The Market Cap of Fundviser Capital (India) Ltd is 113 Cr..
What is the current Stock Price of Fundviser Capital (India) Ltd as on 18 October 2025?
The current stock price of Fundviser Capital (India) Ltd as on 18 October 2025 is 192.
What is the High / Low of Fundviser Capital (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fundviser Capital (India) Ltd stocks is 281/112.
What is the Stock P/E of Fundviser Capital (India) Ltd?
The Stock P/E of Fundviser Capital (India) Ltd is 334.
What is the Book Value of Fundviser Capital (India) Ltd?
The Book Value of Fundviser Capital (India) Ltd is 32.2.
What is the Dividend Yield of Fundviser Capital (India) Ltd?
The Dividend Yield of Fundviser Capital (India) Ltd is 0.00 %.
What is the ROCE of Fundviser Capital (India) Ltd?
The ROCE of Fundviser Capital (India) Ltd is 3.76 %.
What is the ROE of Fundviser Capital (India) Ltd?
The ROE of Fundviser Capital (India) Ltd is 2.88 %.
What is the Face Value of Fundviser Capital (India) Ltd?
The Face Value of Fundviser Capital (India) Ltd is 10.0.